Virus News and Research

Latest Virus News and Research

Canadians with hemophilia A can use new treatment option, XYNTHA

Canadians with hemophilia A - a rare, inherited blood-clotting disorder - now have a new treatment option with the introduction of XYNTHA(TM), a recombinant factor VIII product for both the control and prevention of bleeding episodes and surgical prophylaxis.

2 Dec 2009

Universal Access and Human Rights: A central theme for World AIDS Day 2009

More than 33.4 million people are living with HIV/AIDS in the world today with 2.7 million new infections occurring each year. FHSSA reports, Sub-Saharan Africa is unequally impacted by HIV/AIDS, with 71% of new infections each year.

2 Dec 2009

New patented technology to combat healthcare-associated infections

Independent testing performed at ATS Labs, an internationally recognized antimicrobial testing laboratory, demonstrated that PerfectClean with Micrillon wipers eliminated biological contaminants in a very short time. This promising technology has the potential to impact disinfection practices in the healthcare market.

2 Dec 2009

World AIDS Day: IAC to be held in D.C.; examination of Obama's HIV/AIDS efforts; UNICEF report

During a briefing on the eve of World AIDS Day Monday, Secretary of State Hillary Rodham Clinton said that the International AIDS Society (IAS) has chosen Washington, D.C., to host the 2012 International AIDS Conference (IAC) now that the "decades-old ban on HIV-positive visitors" to the U.S. has been lifted, Agence France-Presse reports (11/30).

2 Dec 2009

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

MicroDose Therapeutx Inc. today announced that it has acquired a portfolio of compounds for the potential treatment of chronic constipation, irritable bowel syndrome with constipation (IBS-C) and other diseases, from Epix Pharmaceuticals, Inc. (EPIX) (Lexington, MA).

2 Dec 2009

CHG Healthcare Services implements campaign to lessen the spread of H1N1 among employees

With the height of seasonal flu season approaching and the pandemic of H1N1 in the headlines, CHG Healthcare Services has designed and mobilized a campaign to keep employees informed of the latest flu trends affecting their offices.

2 Dec 2009

CRO to run CEL-SCI's upcoming Phase III clinical trial

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.

1 Dec 2009

Swine flu cases appear to have peaked

The current wave of pandemic H1N1 appears to have peaked, with four weeks of declines in several key indicators, the Centers for Disease Control and Prevention said Monday. Despite the decrease, the outbreak is continuing to take a heavy toll of hospitalizations and deaths, especially among children.

1 Dec 2009

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

Ardea Biosciences, Inc. announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This

1 Dec 2009

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

Trellis Bioscience, Inc. announced today the granting of a worldwide exclusive license to MedImmune, LLC, the global biologics unit of AstraZeneca, to develop and commercialize Trellis’ antibodies directed against the respiratory syncytial virus (RSV).

1 Dec 2009

Russian hepatitis C virus drug market to reach $327M by 2013: Decision Resources

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the hepatitis C virus drug market in Russia will grow nine percent annually over the 2008 - 2013 study period, reaching $327 million by 2013.

1 Dec 2009

Department of Health reminds Pennsylvanians to be tested regularly for HIV

In recognition of World AIDS Day on Dec. 1, Department of Health Secretary Everette James today reminded Pennsylvanians to be tested regularly for HIV - the virus that causes AIDS.

1 Dec 2009

Mechanism blocking HIV-1 from entering cells identified

Publishing in PLoS Pathogens, researchers at from the Kimmel Cancer Center at Jefferson have found a novel mechanism by which drugs block HIV-1 from entering host cells.

1 Dec 2009

Portuguese scientists identify a molecular mechanism that can lead to metastases in breast cancers

Portuguese scientists identified a molecular mechanism that can lead to metastases (spread of the cancer from the original site to other remote parts of the body) in breast cancers. Abnormally high levels of P-cadherin - an adhesion molecule that enables cells to bind together - occur in about a third of all breast cancers and are associated with poor prognosis.

1 Dec 2009

Members of priority groups to receive H1N1 vaccines from Department of Health

The Department of Health reminded Pennsylvanians they can begin making appointments today to be vaccinated against the H1N1 flu virus.

1 Dec 2009

Avioq receives premarket approval from FDA for Avioq HIV-1 Microelisa System

Avioq, Inc. announced it has received premarket approval from the U.S. Food and Drug Administration (FDA) for the Avioq HIV-1 Microelisa System.

1 Dec 2009

Reductionist model provides new insights on HIV infection

A major obstacle to HIV research is the virus's exquisite specialisation for its human host - meaning that scientists' traditional tools, like the humble lab mouse, can deliver only limited information. Now, a team of researchers writing in BioMed Central's open access Journal of Biology have made an ingenious assault on this problem by creating a mouse that has key features of HIV infection without being infected with HIV.

1 Dec 2009

Americans living in the Southern region may have elevated risk of dying from stroke

The "stroke belt" has a tight hold. People born in the Southern stroke belt have a higher risk of dying from stroke as adults, even if they later move away, compared to people who were born in other parts of the country.

1 Dec 2009

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the Company has finalized a "Patent License Agreement with Los Alamos National Security."

30 Nov 2009

Tripep completes phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio’s electroporation technology.

30 Nov 2009

Virus News and Research

Latest Virus News and Research

Canadians with hemophilia A can use new treatment option, XYNTHA

Universal Access and Human Rights: A central theme for World AIDS Day 2009

New patented technology to combat healthcare-associated infections

World AIDS Day: IAC to be held in D.C.; examination of Obama's HIV/AIDS efforts; UNICEF report

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

CHG Healthcare Services implements campaign to lessen the spread of H1N1 among employees

CRO to run CEL-SCI's upcoming Phase III clinical trial

Swine flu cases appear to have peaked

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

Russian hepatitis C virus drug market to reach $327M by 2013: Decision Resources

Department of Health reminds Pennsylvanians to be tested regularly for HIV

Mechanism blocking HIV-1 from entering cells identified

Portuguese scientists identify a molecular mechanism that can lead to metastases in breast cancers

Members of priority groups to receive H1N1 vaccines from Department of Health

Avioq receives premarket approval from FDA for Avioq HIV-1 Microelisa System

Reductionist model provides new insights on HIV infection

Americans living in the Southern region may have elevated risk of dying from stroke

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Tripep completes phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in